Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Quantum-Si ( (QSI) ).
On August 8, 2025, Quantum-Si Incorporated updated its corporate presentation, highlighting its strategic positioning and growth in the proteomics market. The company reported a 33% year-over-year growth in its user base for the first half of 2025 and announced the introduction of multiple instrument acquisition options. With a well-capitalized position and a cash runway into Q2 2028, Quantum-Si is poised to expand its market presence further. The company’s Proteus platform, expected to launch in the second half of 2026, is designed to address a broad range of proteomics analysis methods, potentially enhancing its competitive edge in the industry.
The most recent analyst rating on (QSI) stock is a Buy with a $3.50 price target. To see the full list of analyst forecasts on Quantum-Si stock, see the QSI Stock Forecast page.
Spark’s Take on QSI Stock
According to Spark, TipRanks’ AI Analyst, QSI is a Neutral.
Quantum-Si’s overall stock score is primarily impacted by its challenging financial performance and weak valuation metrics. While technical indicators suggest bearish momentum, strategic initiatives and a strong cash position provide some optimism. The earnings call highlighted positive developments, but financial and market challenges remain significant.
To see Spark’s full report on QSI stock, click here.
More about Quantum-Si
Quantum-Si Incorporated operates in the life sciences industry, focusing on the development and commercialization of proteomics technology. The company offers products such as the Platinum® line of protein sequencing instruments and kits, targeting a large and growing proteomics market valued at over $75 billion. Quantum-Si aims to transform proteomics research with its differentiated core technology and extensive global distribution network.
Average Trading Volume: 9,149,288
Technical Sentiment Signal: Sell
Current Market Cap: $277.4M
See more data about QSI stock on TipRanks’ Stock Analysis page.

